Yelp stock skids on sell downgrade

Shares of Yelp Inc. tumbled nearly 6% Wednesday after the stock was downgraded to sell from neutral at UBS. Analyst Eric Sheridan said the downgrade reflected headwinds that could impact the execution of its turnaround, as well as increased competition that propose a less attractive risk-reward ratio for the stock. His $17 price target implies a 19% decline from Tuesday’s closing price. Shares of Yelp are down nearly 34% over the last three months, vastly underperforming the S&P 500, which is down 3%. They’ve fallen 57% over the last 12 months, versus the index’s 5% decline.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Stocks open higher as oil, global equities rally

U.S. stocks opened higher on Wednesday, tracking a rally in oil prices and solid gains by European equities one day ahead of the closely watched European Central Bank meeting. The S&P 500 opened 6 points, or 0.3%, higher at 1,986. The Dow Jones Industrial Average gained 58 points, or 0.4%, to 17,028 at the open. Meanwhile, the Nasdaq Composite began the day up 19 points, or 0.4%, at 4,666.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

DirecTV outage was caused by an on-the-ground issue

Satellite operator DirecTV on Tuesday lost the ability to show many of its channels due to a technical issue on the ground, and not a solar flare or satellite issue, according to a person familiar with the situation. The AT&T unit has restored service.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Vera Bradley beats fourth-quarter revenue expectations

Vera Bradley Inc.’s stock was indicated higher in premarket trade Wednesday, after the handbag and accessories maker beat fourth-quarter revenue expectations. The company reported net income of $15.7 million, or 41 cents per share, down from $17.3 million, or 43 cents per share, in the year-earlier period. The FactSet consensus was for earnings per share of 41 cents. The company reported revenue of $154.1 million, up from $152.6 million, and above the FactSet consensus of $152.6 million. The fiscal year 2016 marked the second year of a brand turnaround plan and next year, Robert Wallstrom, chief executive officer, said the company believes it can return the company to “solid growth.” “Our top priority continues to be to make Vera Bradley more relevant in order to attract even more new customers to the brand,” Wallstrom said.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Valeant’s stock jumps after adding new directors, including a Pershing Square executive

Valeant Pharmaceuticals International Inc.’s stock surged 4.1% in premarket trade Wednesday, after the drug maker said it added three new independent directors to its board, including Stephen Fraidin, who is the vice chairman of activist investor Pershing Square Capital Management. Valeant said Anders Lonner has stepped down as a director. The other board members added were Fred Eshelman, a former chief executive of Pharmaceutical Product Development Inc. , and Thomas Ross, who served as president of University of North Carolina. Pershing Square, which is Valeant’s third-largest shareholder, according to FactSet, is the hedge fund run by Bill Ackman. The Wall Street Journal had reported late Tuesday that Valeant was in discussions to add three new directors. Valeant’s stock had tumbled 38% year to date through Tuesday, while the S&P 500 had slipped 3.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Valeant’s stock jumps after adding new directors, including a Pershing Square executive

Valeant Pharmaceuticals International Inc.’s stock surged 4.1% in premarket trade Wednesday, after the drug maker said it added three new independent directors to its board, including Stephen Fraidin, who is the vice chairman of activist investor Pershing Square Capital Management. Valeant said Anders Lonner has stepped down as a director. The other board members added were Fred Eshelman, a former chief executive of Pharmaceutical Product Development Inc. , and Thomas Ross, who served as president of University of North Carolina. Pershing Square, which is Valeant’s third-largest shareholder, according to FactSet, is the hedge fund run by Bill Ackman. The Wall Street Journal had reported late Tuesday that Valeant was in discussions to add three new directors. Valeant’s stock had tumbled 38% year to date through Tuesday, while the S&P 500 had slipped 3.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Valeant’s stock jumps after adding new directors, including a Pershing Square executive

Valeant Pharmaceuticals International Inc.’s stock surged 4.1% in premarket trade Wednesday, after the drug maker said it added three new independent directors to its board, including Stephen Fraidin, who is the vice chairman of activist investor Pershing Square Capital Management. Valeant said Anders Lonner has stepped down as a director. The other board members added were Fred Eshelman, a former chief executive of Pharmaceutical Product Development Inc. , and Thomas Ross, who served as president of University of North Carolina. Pershing Square, which is Valeant’s third-largest shareholder, according to FactSet, is the hedge fund run by Bill Ackman. The Wall Street Journal had reported late Tuesday that Valeant was in discussions to add three new directors. Valeant’s stock had tumbled 38% year to date through Tuesday, while the S&P 500 had slipped 3.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Darden provides profit and sales outlook above expectations, names new CFO

Darden Restaurants Inc.’s stock rose 1.3% in light premarket trade Wednesday, after the operator of Olive Garden and LongHorn Steakhouse restaurant chains provided a fiscal third-quarter outlook that was above expectations, and named a chief financial officer. For the quarter ended Feb. 28, the company expects adjusted earnings per share of $1.18 to $1.21, up from 99 cents a year ago, and above the FactSet consensus of $1.06. Same-store sales are expected to rise 6%, above the FactSet consensus of 2.7%. “Our continued success and momentum is a direct result of executing against our plan and maintaining our focus on consistently delivering outstanding guest experiences,” said Chief Executive Eugene Lee. Darden said it appointed Ricardo Cardenas as its CFO, to replace Jeffrey Davis who left to pursue other opportunities. Cardenas has been with Darden since 1984, most recently at chief strategy officer. The stock has gained 1.5% year to date through Tuesday, while the S&P 500 has lost 3.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News